About the Program
Up to 10 biotech startups will be selected for a free Benchling “Ask the Expert” session, on the 28th of February, where a Benchling employee will demonstrate how biotech scientists can maximize productivity in the lab.
Up to three of these 10 startups will be selected to receive a complementary 1:1 solution consulting session with Benchling, and will each receive up to 5 free software licenses for their company for one year - with the caveat that the startup agrees to pay the associated implementation costs of Benchling. After the 12 months of continued free usage have lapsed, the selected companies will need to pay for ongoing usage of the Benchling solutions.
About Benchling R&D Cloud
Benchling is the pioneer of the R&D Cloud software that powers the biotechnology industry. More than 200,000 scientists at over 900 companies and 7,500 research institutions globally have adopted Benchling's R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D Cloud helps these organizations modernize their scientific processes and accelerate collaboration so they can convert the complexity of biology into world-changing results. For more, please visit Benchling.com.
Apply now to benefit from expert advice on how to improve your R&D, and further expand your network.
This program is only open to companies that are not using a paid version of Benchling yet.
Agenda
16:00 - Welcome from Venturelab
16:05 - Introduction to the startups and to Benchling
16:15 - Workshop Session: How can Benchling's platform accelerate your R&D lifecycle?
17:30 - Networking & Ápero
18:30 - Closing
Speakers
Abla Benabderrazik is a Scientific Solutions Consultant (SSC) at Benchling, moved to Switzerland in 2013 where she studied Chemical Engineering & Biotechnology at EPFL. Following the successful completion of her graduate studies at EPFL, she started her carreer as a Technical Sales Specialist at Saniswiss, supporting healthcare institutions in their biosafety strategy. In 2020, she joined Benchling as a SSC where she has been supporting over 150 startups in their R&D data management strategy.
Anastasija Nufer is an Account Executive (AE) at Benchling, studied Neurobiology at ETH. Leaving the laboratory bench in 2018, she worked at Bruker as a Microbiology Sales Specialist - equipping biopharma companies with the newest diagnostic technologies to enable faster microorganism identification. In 2021, she joined Benchling as an AE, where she has worked with more than 130 companies to develop their R&D data management strategy. Currently, she is undertaking her MBA at the University of St.Gallen.